INKT
Mink Therapeutics Inc
11.00$
-3.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | -100.0% | – | +0.2% | +73.1% | +332.9% | -100.0% | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +17.5% | +13.6% | +4.5% | +0.4% | +33.4% | +20.4% | +13.6% | +3.0% | +0.2% | +0.5% | -16.2% | +38.9% | -14.0% | -5.8% | -3.9% | -10.5% | -11.7% | -6.5% | 0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | -19.5% | -68.5% | +293.2% | +15.7% | -7.0% | +18.5% | +33.6% | +11.3% | +4.7% | -5.5% | -27.8% | +8.7% | -24.8% | -3.4% | -23.0% | -27.8% | -70.6% | +160.1% | -10.2% | +45.7% | -37.8% | +32.4% | -20.4% | +56.7% | – | |
| – | +0.0% | -17.3% | -33.9% | +92.9% | +45.9% | -6.1% | +189.9% | -11.2% | -13.1% | +0.8% | +13.0% | -20.1% | +7.5% | +0.6% | +21.9% | -41.5% | -17.1% | +9.5% | -30.4% | +157,009.2% | -99.9% | +99,757.5% | +264.2% | -75.1% | -99.9% | – | |
| – | +0.0% | +64.8% | -74.3% | +141.2% | +52.7% | -26.4% | +52.3% | +16.8% | +4.4% | +3.8% | -1.4% | -26.0% | +8.3% | -17.8% | +5.3% | -30.7% | -24.4% | -42.6% | +31.7% | +14.8% | +46.6% | -19.1% | +9.9% | -12.1% | +11.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | +7.5% | +8.3% | +8.2% | +9.5% | -99.8% | -45.2% | +3,010.5% | +252.4% | +72.5% | +104,696.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +319.5% | -39.6% | -1,182.0% | – | +25,938.3% | -500.2% | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.